Sign in for the best experience.
Everything we publish is designed to keep you up-to-date on the latest news, approaches, and ideas in chest medicine. From the most relevant research findings to the most significant clinical guidelines, these are the highly accredited resources you count on from CHEST.
Advertisement
Used throughout the world, our multidisciplinary guidelines help translate quality evidence into applicable recommendations that enrich patient care and improve health outcomes.
FEATURED GUIDELINE
Biologic Management in Severe Asthma for Adults
This guideline examines the literature related to choice of biologic agent in patients with severe asthma and consists of seven evidence-based recommendations to optimize their use.
Management of Patients With Early-Stage Non-Small Cell Lung Cancer
This CHEST guideline examines the literature on primary treatment of patients with stage I and II non-small cell lung cancer and consists of 17 evidence-based recommendations that surgeons can implement in their own practice.
Access CHEST’s full collection of guidelines, expert panel reports, and consensus statements.
Guideline topics
Airway Disorders
Chest Infections
Clinical Pulmonary
Critical Care
Interstitial Lung Disease
Interventional Pulmonary
Pulmonary Vascular
Thoracic Oncology
The CHEST® journal portfolio features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine—pulmonary, critical care, and sleep medicine—and related disciplines. With a loyal readership base, the portfolio, including the journals CHEST, CHEST® Critical Care, and CHEST® Pulmonary, is one of the most highly regarded, and up-to-date sources of clinical knowledge in the field.
Aspergillus fumigatus Sensitization Is Associated With High-Risk Bronchiectasis
Fungal sensitization is an increasingly recognized endophenotype in chronic respiratory disease; however, its role in bronchiectasis remains poorly defined. An international, multicenter study in the journal CHEST® explored the prevalence and clinical implications of fungal sensitization in bronchiectasis.
Serial MRI Measures Short-Term Parenchymal Changes in Neonatal Bronchopulmonary Dysplasia
The longitudinal trajectory of parenchymal disease remains poorly characterized. A prospective cohort study in the journal CHEST® investigated the one-month trajectory of lung parenchymal disease in infants with moderate to severe bronchopulmonary dysplasia, as assessed by quantitative MRI measures of lung volume and tissue density.
See if you can answer this question based on a CHEST clinical practice guideline.
Each month, the journal CHEST Editor in Chief Peter Mazzone, MD, MPH, FCCP, adds context and commentary to important articles featured in the new issue.
OPEN ACCESS JOURNALS | Submit your research to be published in our new journals. CHEST® CRITICAL CARE » | CHEST® PULMONARY »
Whatever your specialty, CHEST has a topic collection that you’ll be interested in. Uncover insights from key opinion leaders, find CME opportunities, and discover original research articles.
Clinical advances, practice management updates, medical conference highlights—reading the CHEST Physician® publication is the easiest way to be in the know every month.
Originally aired: May 1, 2026
CHEST® journal Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key articles published in the May 2026 issue.
Hear about research into the association between long-term proton pump inhibitor use and exacerbation risk in patients with chronic obstructive airway diseases.
Hear about research into the prevalence of Pseudomonas aeruginosa among patients with nosocomial respiratory infections in the ICU.